Clinical Evidence
IBDV has been proven clinically safe and effective against five different viruses in acute and chronic diseases. IBDV will, therefore, belong to the highly select 10% class of successful drug development cases.
IBDV has been proven clinically safe and effective against five different viruses in acute and chronic diseases. IBDV will, therefore, belong to the highly select 10% class of successful drug development cases.